Spots Global Cancer Trial Database for combined therapy using gemcitabine and cisplatin chemotherapy, lenvatinib and adebrelimab
Every month we try and update this database with for combined therapy using gemcitabine and cisplatin chemotherapy, lenvatinib and adebrelimab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma | NCT06298968 | Intrahepatic Ch... | combined therap... | 18 Years - 75 Years | Nanfang Hospital, Southern Medical University |